http://www.zacks.com/stock/news/532006/glaxos-benlysta-gets-positive-chmp-opinion-for-use-in-kids?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-532006
Sep 23, 2019 - Glaxo's (GSK) SLE drug Benlysta gets a favorable CHMP opinion that recommends an approval for intravenous formulation in pediatric patients.
zc:3661503876147696099
0
http://www.zacks.com/stock/news/521160/astrazenecas-farxiga-gets-fast-track-tag-for-heart-failure?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-521160
Sep 16, 2019 - The FDA assigns a Fast Track status to AstraZeneca's (AZN) Farxiga to reduce the risk of cardiovascular death or worsening of heart failure in adult patients with HFrEF and HFpEF.
zc:-8155117072895118046
0
http://www.zacks.com/stock/news/520833/breast-cancer-drugs-may-inflame-lungs-per-fda-safety-alert?cid=CS-ZC-FT-analyst_blog|industry_focus-520833
Sep 16, 2019 - The FDA approves new warnings about inflammation risk to be added to labels of Pfizer's (PFE) Ibrance, Eli Lilly's (LLY) Verzenio and Novartis' (NVS) Kisqali.
zc:-3250736619040137410
0
http://www.zacks.com/stock/news/516828/pharma-stock-roundup-pipeline-regulatory-updates-from-gsk-pfe-others?cid=CS-ZC-FT-analyst_blog|stock_roundup-516828
Sep 13, 2019 - Glaxo's (GSK) Nucala gets FDA nod for use in kids. Pfizer (PFE), Allergan (AGN) & Roche (RHHBY) give regular pipeline/regulatory updates.
zc:2365231250824597590
0
http://www.zacks.com/research-daily/511170/top-analyst-reports-for-caterpillar-general-motors-citigroup?cid=CS-ZC-FT-research_daily-511170
Sep 10, 2019 - Top Analyst Reports for Caterpillar, General Motors & Citigroup
zc:-2420771518507777787
0
http://www.zacks.com/stock/news/510993/are-you-looking-for-a-high-growth-dividend-stock-eli-lilly-lly-could-be-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-510993
Sep 10, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eli Lilly (LLY) have what it takes? Let's find out.
zc:-9044262284363129237
0
https://seekingalpha.com/article/4290610-eli-lilly-company-lly-presents-iaslc-2019-world-conference-lung-cancer-slideshow?source=feed_sector_healthcare
Sep 09, 2019 - The following slide deck was published by Eli Lilly and Company in conjunction with this event.
0
sa:3750424998348121663
0
http://www.zacks.com/stock/news/509890/lillys-ret-inhibitor-shrinks-tumors-in-lung-cancer-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-509890
Sep 09, 2019 - Lilly (LLY) presents data from the LIBRETTO-001 study on selpercatinib for the treatment of RET fusion-positive non-small cell lung cancer. The candidate as a monotherapy attains 68% ORR.
zc:-656304842677465997
0
http://www.zacks.com/stock/news/509529/novartis-announces-positive-long-term-data-on-migraine-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-509529
Sep 09, 2019 - Novartis' (NVS) migraine drug Aimovig is effective and safe in treating patients with episodic migraine in a long-term study.
zc:8128220372482317111
0
https://www.fool.com/investing/2019/09/05/biotech-stocks-with-big-catalysts-in-september.aspx?source=iedfolrf0000001
Sep 05, 2019 - Two presentations at the World Conference on Lung Cancer will make a big difference for at least four different drugmakers.
0
fool:391961164409161609
0